These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 33811335)

  • 1. The relation between maternal obesity and placenta accreta spectrum: A multinational database study.
    Vieira MC; Rijken MJ; Braun T; Chantraine F; Morel O; Schwickert A; Stefanovic V; van Beekhuizen H; Collins SL;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():50-57. PubMed ID: 33811335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro fertilization as an independent risk factor for placenta accreta spectrum.
    Salmanian B; Fox KA; Arian SE; Erfani H; Clark SL; Aagaard KM; Detlefs SE; Aalipour S; Espinoza J; Nassr AA; Gibbons WE; Shamshirsaz AA; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2020 Oct; 223(4):568.e1-568.e5. PubMed ID: 32360847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Number of Prior Cesareans and Early Preterm Delivery in Women with Abnormal Placentation.
    Oben A; Ausbeck EB; Gazi MN; Subramaniam A; Harper LM; Szychowski JM; Tita AT
    Am J Perinatol; 2021 Mar; 38(4):326-331. PubMed ID: 32992353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between short inter-pregnancy interval and placenta previa and placenta accreta spectrum with respect to maternal age at first cesarean delivery.
    Liang Y; Zhang L; Huang L; Li Y; Chen J; Bi S; Huang M; Tan H; Lai S; Liang J; Gu S; Jia J; Wen S; Wang Z; Cao Y; Wang S; Xu X; Feng L; Zhao X; Zhao Y; Zhu Q; Qi H; Zhang L; Li H; Du L; Chen D
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2192853. PubMed ID: 36966813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study.
    Morlando M; Schwickert A; Stefanovic V; Gziri MM; Pateisky P; Chalubinski KM; Nonnenmacher A; Morel O; Braun T; Bertholdt C; Van Beekhuizen HJ; Collins SL;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():41-49. PubMed ID: 33713033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of emergency Cesarean delivery in pregnancies complicated by placenta previa with or without placenta accreta spectrum disorder: analysis of ADoPAD cohort.
    ADoPAD (Antenatal Diagnosis of Placental Attachment Disorders) Study Group
    Ultrasound Obstet Gynecol; 2024 Feb; 63(2):243-250. PubMed ID: 37698306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder.
    Han X; Guo Z; Yang X; Yang H; Ma J
    JAMA Netw Open; 2022 Aug; 5(8):e2228002. PubMed ID: 35994286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
    Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center.
    Varlas VN; Bors RG; Birsanu S; Maxim B; Clotea E; Mihailov M
    J Med Life; 2021; 14(3):367-375. PubMed ID: 34377203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta Accreta Spectrum Without Placenta Previa.
    Carusi DA; Fox KA; Lyell DJ; Perlman NC; Aalipour S; Einerson BD; Belfort MA; Silver RM; Shamshirsaz AA
    Obstet Gynecol; 2020 Sep; 136(3):458-465. PubMed ID: 32769646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for placenta accreta spectrum: findings from the Japan environment and Children's study.
    Kyozuka H; Yamaguchi A; Suzuki D; Fujimori K; Hosoya M; Yasumura S; Yokoyama T; Sato A; Hashimoto K;
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):447. PubMed ID: 31775687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study.
    Schwickert A; van Beekhuizen HJ; Bertholdt C; Fox KA; Kayem G; Morel O; Rijken MJ; Stefanovic V; Strindfors G; Weichert A; Weizsaecker K; Braun T;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():29-40. PubMed ID: 33524163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa.
    Ogawa K; Jwa SC; Morisaki N; Sago H
    Arch Gynecol Obstet; 2022 Mar; 305(3):607-615. PubMed ID: 34448037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study.
    Fitzpatrick KE; Sellers S; Spark P; Kurinczuk JJ; Brocklehurst P; Knight M
    PLoS One; 2012; 7(12):e52893. PubMed ID: 23300807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical risk factors for placenta previa-placenta accreta.
    Miller DA; Chollet JA; Goodwin TM
    Am J Obstet Gynecol; 1997 Jul; 177(1):210-4. PubMed ID: 9240608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.
    di Pasquo E; Ghi T; Calì G; D'Antonio F; Fratelli N; Forlani F; Prefumo F; Kaihura CT; Volpe N; Dall'Asta A; Frusca T
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):460-466. PubMed ID: 31503353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risk factors and maternal outcomes of unsuspected placenta accreta spectrum disorders: a retrospective cohort study.
    Zhao J; Li Q; Liao E; Shi H; Luo X; Zhang L; Qi H; Zhang H; Li J
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):76. PubMed ID: 38262978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.